Recent Updates
Recently added Catalysts
MMSI Positive Sentiment

Mile-Markers to Breast Cancer Recovery with SCOUT®: The Tara Zuzga Story

Key Takeaway: Tara Zuzga's journey through breast cancer highlights the importance of early detection and innovative treatment options like SCOUT Radar Localization. After discovering a mass, she quickly sought medical help and began chemotherapy. Thanks to her proactive approach and the support of her healthcare team, Tara achieved a cancer-free status in January 2022, marking a significant milestone in her recovery.
Price reaction · baseline $69.02 (2023-09-29 close) · hit pre-market · 1 other MMSI headline(s) in the window, move may be shared
day 0 close · peak
-2.6%

Market Sentiment Analysis

POSITIVE FACTORS

  • Tara Zuzga's early detection led to successful treatment.
  • The SCOUT technology enhances surgical precision and outcomes.
  • Tara's story showcases resilience and positivity during treatment.
  • She celebrated milestones in her recovery journey.

Full Press Release Details

Merit Medical is committed to reducing the burden of breast cancer on patients and their loved ones—patients like Tara Zuzga.
“May of 2021, I was out on a date night with my husband,” recalled Tara. “While I was in the restroom fluffing my hair, I noticed a mass under my right armpit.”
Working in the healthcare industry and having a family history of breast cancer, Tara knew that early detection saves lives. Throughout her life, she diligently underwent regular mammograms and ultrasounds. For a mass like this, however, she couldn’t wait for her next exam. With the support of her husband, who also works in the medical field, Tara connected with Dr. Blumencranz, a breast cancer specialist.
With an accurate diagnosis of breast cancer, she started chemotherapy two weeks later.
AN EXCELLENT CANDIDATE FOR SCOUT®
Tara’s case made her an excellent candidate for SCOUT Radar Localization , wireless technology designed to help treat early-stage breast cancer patients. Once a SCOUT reflector—a marking device smaller than a grain of rice—is placed inside a lump during biopsy, surgeons can precisely target the affected tissue to pinpoint its location within 1 mm. This can mean more successful surgeries, optimized breast conservation strategies, and enhanced outcomes for women.
With Dr. Blumencranz’ help, Tara set off on her journey toward recovery. But she didn’t let her diagnosis slow her down, and she made sure every moment counted.
Tara and her husband continued having special date nights the evening prior to her bi-monthly chemo treatments. “He would take me out just to appreciate that moment before the next morning,” said Tara. “Which was a big deal.”
“She’s like super woman. She’d have her chemo, and then she’d go out walking,” reflected Tara’s husband. “All in all, she was the warrior in all of this.”
YOU’RE NO LONGER MY PATIENT
In January of 2022, Tara received the news she’d been hoping for.
She was cancer-free.
“The day Dr. Blumencranz told me, ‘You’re no longer my patient,’ we both stood there and cried,” said Tara. “When they say we’re checking you out, it’s a really big deal. It’s as big of a deal as ringing the bell for your last chemo. Those mile-markers are everything.”
Watch Tara’s journey to becoming cancer-free.

Frequently Asked Questions

What is SCOUT technology?

SCOUT technology is a wireless localization system that helps surgeons precisely target breast cancer tissue during surgery.

How did Tara Zuzga detect her breast cancer?

Tara noticed a mass under her armpit during a date night and sought immediate medical attention.

What milestone did Tara celebrate after her treatment?

Tara celebrated being declared cancer-free by her doctor in January 2022.

What role did Tara's husband play in her journey?

Tara's husband supported her throughout her treatment, ensuring they cherished special moments together.

Last updated: Oct 2, 2023